265 related articles for article (PubMed ID: 8392181)
1. chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects.
Asplin I; Galasko G; Larner J
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5924-8. PubMed ID: 8392181
[TBL] [Abstract][Full Text] [Related]
2. Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls.
Sun TH; Heimark DB; Nguygen T; Nadler JL; Larner J
Biochem Biophys Res Commun; 2002 May; 293(3):1092-8. PubMed ID: 12051772
[TBL] [Abstract][Full Text] [Related]
3. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus.
Kennington AS; Hill CR; Craig J; Bogardus C; Raz I; Ortmeyer HK; Hansen BC; Romero G; Larner J
N Engl J Med; 1990 Aug; 323(6):373-8. PubMed ID: 2370888
[TBL] [Abstract][Full Text] [Related]
4. Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats.
Farese RV; Standaert ML; Yamada K; Huang LC; Zhang C; Cooper DR; Wang Z; Yang Y; Suzuki S; Toyota T
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11040-4. PubMed ID: 7972005
[TBL] [Abstract][Full Text] [Related]
5. Circulating factors and insulin resistance. II. The action of the novel myo-inositol cyclic 1,2-inositol phosphate phosphoglycan insulin antagonist from human plasma in regulating pyruvate dehydrogenase phosphatase.
Galasko GT; Abe S; Lilley K; Zhang C; Larner J
J Clin Endocrinol Metab; 1996 Mar; 81(3):1051-7. PubMed ID: 8772575
[TBL] [Abstract][Full Text] [Related]
6. Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo.
Huang LC; Fonteles MC; Houston DB; Zhang C; Larner J
Endocrinology; 1993 Feb; 132(2):652-7. PubMed ID: 8425485
[TBL] [Abstract][Full Text] [Related]
7. Determination of urinary Myo-/chiro-inositol ratios from Korean diabetes patients.
Jung TS; Hahm JR; Kim JJ; Jung JH; Kang MY; Moon SW; Lee KW; Kim HC; Lee JD; Kim JH; Kim DR; Chung SI
Yonsei Med J; 2005 Aug; 46(4):532-8. PubMed ID: 16127779
[TBL] [Abstract][Full Text] [Related]
8. D-chiro-inositol--its functional role in insulin action and its deficit in insulin resistance.
Larner J
Int J Exp Diabetes Res; 2002; 3(1):47-60. PubMed ID: 11900279
[TBL] [Abstract][Full Text] [Related]
9. Urinary chiro-inositol and myo-inositol excretion is elevated in the diabetic db/db mouse and streptozotocin diabetic rat.
Kawa JM; Przybylski R; Taylor CG
Exp Biol Med (Maywood); 2003 Sep; 228(8):907-14. PubMed ID: 12968062
[TBL] [Abstract][Full Text] [Related]
10. Relationships of plasma C-peptide and gender to the urinary excretion of inositols in older people.
Campbell WW; Ostlund RE; Joseph LJ; Farrell PA; Evans WJ
Horm Metab Res; 2001 Jan; 33(1):44-51. PubMed ID: 11280715
[TBL] [Abstract][Full Text] [Related]
11. Phosphoinositol glycan derived mediators and insulin resistance. Prospects for diagnosis and therapy.
Larner J; Allan G; Kessler C; Reamer P; Gunn R; Huang LC
J Basic Clin Physiol Pharmacol; 1998; 9(2-4):127-37. PubMed ID: 10212830
[TBL] [Abstract][Full Text] [Related]
12. Urinary chiro- and myo-inositol levels as a biological marker for type 2 diabetes mellitus.
Hong JH; Jang HW; Kang YE; Lee JH; Kim KS; Kim HJ; Park KR; Ku BJ
Dis Markers; 2012; 33(4):193-9. PubMed ID: 22960342
[TBL] [Abstract][Full Text] [Related]
13. Insulin mediators in man: effects of glucose ingestion and insulin resistance.
Shashkin PN; Shashkina EF; Fernqvist-Forbes E; Zhou YP; Grill V; Katz A
Diabetologia; 1997 May; 40(5):557-63. PubMed ID: 9165224
[TBL] [Abstract][Full Text] [Related]
14. Antihyperglycemic effects of 3-O-methyl-D-chiro-inositol and D-chiro-inositol associated with manganese in streptozotocin diabetic rats.
Fonteles MC; Almeida MQ; Larner J
Horm Metab Res; 2000 Apr; 32(4):129-32. PubMed ID: 10824707
[TBL] [Abstract][Full Text] [Related]
15. In vivo chiro-inositol metabolism in the rat: a defect in chiro-inositol synthesis from myo-inositol and an increased incorporation of chiro-[3H]inositol into phospholipid in the Goto-Kakizaki (G.K) rat.
Pak Y; Hong Y; Kim S; Piccariello T; Farese RV; Larner J
Mol Cells; 1998 Jun; 8(3):301-9. PubMed ID: 9666467
[TBL] [Abstract][Full Text] [Related]
16. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Croze ML; Soulage CO
Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
[TBL] [Abstract][Full Text] [Related]
17. Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes.
Suzuki S; Kawasaki H; Satoh Y; Ohtomo M; Hirai M; Hirai A; Hirai S; Onoda M; Matsumoto M; Hinokio Y
Diabetes Care; 1994 Dec; 17(12):1465-8. PubMed ID: 7882818
[TBL] [Abstract][Full Text] [Related]
18. Relationships between urinary inositol excretions and whole-body glucose tolerance and skeletal muscle insulin receptor phosphorylation.
Stull AJ; Thyfault JP; Haub MD; Ostlund RE; Campbell WW
Metabolism; 2008 Nov; 57(11):1545-51. PubMed ID: 18940392
[TBL] [Abstract][Full Text] [Related]
19. D-chiro-inositol metabolism in diabetes mellitus.
Ostlund RE; McGill JB; Herskowitz I; Kipnis DM; Santiago JV; Sherman WR
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9988-92. PubMed ID: 8234346
[TBL] [Abstract][Full Text] [Related]
20. Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls.
Heimark D; McAllister J; Larner J
Endocr J; 2014; 61(2):111-7. PubMed ID: 24189751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
